Menu
1 min read · estimated
APPROVED USE
What FDA approved
For adults with ROS1-positive NSCLC that is locally advanced or metastatic.
LAMPGEN ANALYSIS
Why it matters
This ROS1 kinase inhibitor was evaluated in both ROS1 inhibitor-naive and previously exposed populations.
What research teams should watch
Confirm the ROS1 result and prior targeted therapy history; coordinate liver and ECG monitoring where appropriate.
PRIMARY RECORDS